Correlation Between Homology Medicines and Biomea Fusion

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Homology Medicines and Biomea Fusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Homology Medicines and Biomea Fusion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Homology Medicines and Biomea Fusion, you can compare the effects of market volatilities on Homology Medicines and Biomea Fusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Homology Medicines with a short position of Biomea Fusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Homology Medicines and Biomea Fusion.

Diversification Opportunities for Homology Medicines and Biomea Fusion

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Homology and Biomea is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Homology Medicines and Biomea Fusion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomea Fusion and Homology Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Homology Medicines are associated (or correlated) with Biomea Fusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomea Fusion has no effect on the direction of Homology Medicines i.e., Homology Medicines and Biomea Fusion go up and down completely randomly.

Pair Corralation between Homology Medicines and Biomea Fusion

Given the investment horizon of 90 days Homology Medicines is expected to generate 0.68 times more return on investment than Biomea Fusion. However, Homology Medicines is 1.46 times less risky than Biomea Fusion. It trades about 0.02 of its potential returns per unit of risk. Biomea Fusion is currently generating about -0.03 per unit of risk. If you would invest  110.00  in Homology Medicines on August 31, 2024 and sell it today you would lose (1.00) from holding Homology Medicines or give up 0.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy8.56%
ValuesDaily Returns

Homology Medicines  vs.  Biomea Fusion

 Performance 
       Timeline  
Homology Medicines 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Homology Medicines has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Homology Medicines is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Biomea Fusion 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biomea Fusion has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Biomea Fusion is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Homology Medicines and Biomea Fusion Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Homology Medicines and Biomea Fusion

The main advantage of trading using opposite Homology Medicines and Biomea Fusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Homology Medicines position performs unexpectedly, Biomea Fusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomea Fusion will offset losses from the drop in Biomea Fusion's long position.
The idea behind Homology Medicines and Biomea Fusion pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Transaction History
View history of all your transactions and understand their impact on performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes